- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05721378
Permissive Weight Bearing in Displaced Intra-articular Calcaneal Fractures (PIONEER)
(Cost-)effectiveness of Permissive Weight Bearing in Surgically Treated Trauma Patients with Displaced Intra-Articular Calcaneal Fractures: a Multicenter, Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: Of all fractures, 1-2% involve the calcaneus. Often surgical treatment is needed. Even after successful treatment it requires long rehabilitation with major impact on daily life and socio-economic aspects. Anatomic surgical restoration does not prevent gait disturbances or persistent foot pain. An adequate rehabilitation program is mandatory to maximize foot stability.
Objective: Evidence showing which rehabilitation protocol is best for both fracture healing and quality of life for patients with Displaced Intra-Articular Calcaneal Fractures (DIACFs) is mostly lacking. This study has the aim to answer the question whether surgically treated patients with DIACFs following the Permissive Weight Bearing protocol (PWB) have better functional outcomes compared to patients with Restricted Weight Bearing protocol after 12 weeks (RWB) measured with the American Orthopaedic Foot & Ankle Society (AOFAS) Score. The study hypothesizes that patients with DIACFs following the PWB protocol will have a better quality of life (HR-QOL) compared to patients who followed the RWB protocol.
The hypothesis is that there will be lower costs without any radiographic differences for surgically treated (irrespective of technique used) patients with DIACFs following a PWB protocol comparing to the current AO (Arbeitsgemeinschaft für Osteosynthesefragen) standard care: the RWB protocol.
Study design: Multi-center randomized controlled trial
Study population: Presence of surgically (extended lateral, sinus tarsi or percutaneous approach) fixed DIACFs classified as Sanders type II to IV, age 18-67 years (labor force). Patients must be able to understand and follow weight bearing instructions. Patients will only be included after written informed consent is obtained.
Groups (intervention and control): Patients with DIACFs will be randomly allocated to one of the rehabilitation protocols, either PWB or RWB.
Main study parameters/endpoints: Primary objective: functional outcome. Secondary outcomes: quality of life, differences in radiographic parameters, complications, cost effectiveness and differences in surgical techniques.
Nature and extent of the burden: The PWB protocol aims to restore weight bearing faster than RWB protocol in DIACFs. Early postoperative weight bearing poses the risk of increased complications, such as secondary displacement of the fracture or failure of fracture fixation. Previous analysis of this protocol in other lower extremity fractures has shown a safe complication rate, although data from prospective randomized trials in calcaneus fractures are lacking. Follow-up is standardized according to current trauma guidelines, namely at time points 2, 6, 12 weeks and 6 months. The radiation exposure will not be different from standard of care. Therefore, the burden for participants is considered minimal, with no significant health risks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Coen Verstappen, MD
- Phone Number: +31(0)43-3877489
- Email: coen.verstappen@mumc.nl
Study Locations
-
-
-
Amsterdam, Netherlands
- Not yet recruiting
- Amsterdam University Medical Center
-
Contact:
- Tim Schepers
- Phone Number: MD
-
Arnhem, Netherlands
- Not yet recruiting
- Rijnstate Hospital
-
Contact:
- Albert Pull ter Gunne, MD
-
Breda, Netherlands
- Not yet recruiting
- Amphia Hospital
-
Contact:
- Niels Berende, MD
-
Den Haag, Netherlands
- Not yet recruiting
- Haaglanden Medical Center
-
Contact:
- Jochem Hoogendoorn, MD
-
Eindhoven, Netherlands
- Not yet recruiting
- Catharina Hospital
-
Contact:
- Alexander van der Veen, MD
-
Gouda, Netherlands
- Not yet recruiting
- Groene Hart Hospital
-
Contact:
- Jan Siert Reinders, MD
-
Maastricht, Netherlands
- Recruiting
- Maastricht University Medical Center +
-
Contact:
- Martijn Poeze, Prof.
-
Nijmegen, Netherlands
- Recruiting
- Radboud University Medical Center
-
Contact:
- Erik Hermans, MD
-
Rotterdam, Netherlands
- Not yet recruiting
- Maasstad Hospital
-
Contact:
- Kees van der Vlies, MD
-
Sittard, Netherlands
- Not yet recruiting
- Zuyderland Medical Center
-
Contact:
- Raoul van Vugt, MD
-
Tilburg, Netherlands
- Not yet recruiting
- Elisabeth-Twee Steden Hospital
-
Contact:
- Hilco Theeuwes, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Surgically treated trauma patients with isolated unilateral DIACFs, less than 6 weeks after trauma, Sanders type II-IV (14)
- Age between 18 and 67 years old (labor force)
- Being able to understand the questionnaires and measurement instructions
- Indication for open/closed reduction and internal fixation
- Written Informed Consent
Exclusion Criteria:
- Acute or existing amputation (upper limb, lower limb, feet)
- Open calcaneal fractures (excluding medial wound without compromising surgical approach)
- Bilateral fractures of the lower extremities
- Unable to comply to the PWB protocol due to pre-existing conditions of the arms and legs (e.g. unable to use crotches due to hemiparalysis)
- Severe non-fracture related comorbidity of the lower extremity
- Pre-existent immobility (loss of muscle function of one or both legs)
- Dependent in activities of daily living (e.g. due to dementia, Alzheimer, New York Heart Association class IV angina, heart failure or oxygen-dependent chronic obstructive pulmonary disease)
- Rheumatoid arthritis of the lower extremities
- Severe psychiatric comorbidities that lead to inability to comply with the treatment protocol
- Pathologic fractures (metastasis, secondary osteoporosis)
- Peripheral neuropathy and/or diabetes
- Alcohol- or drug abuse preventing adequate follow-up
- Primary indication for arthrodesis subtalar joint
- Two or more fractures of the upper and/or lower extremities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Permissive Weight Bearing group
Rehabilitation following the Permissive Weight Bearing (PWB) protocol
|
The Permissive Weight Bearing (PWB) protocol allows earlier post-operative permissive weight bearing, where progression of weight bearing is guided by the subjective experience (for example: pain, weight bearing tolerance) of the patient and the clinical expertise of the treating physician and therapist.
Patients allocated to the PWB protocol start weight bearing after wound healing is achieved (approximately two weeks after the operation).
Consequently, patients are stimulated to bear as much weight as tolerated by pain and comfort.
Treatment will take place according to the PROMETHEUS protocol (treatment- and evaluation protocol).
The protocol contains a number of weight bearing milestones (e.g.
walking with two crutches, walking with two canes, walking with one cane and walking without any walking aids).
The treating physiotherapist or physician records the dates that these milestones are reached in the study database.
Other Names:
|
|
Active Comparator: Restrictive Weight Bearing group
Rehabilitation following the Restrictive Weight Bearing (RWB) protocol
|
The Restrictive Weight Bearing (RWB) protocol consists of 8 to 12 weeks of postoperative restricted weight (0-10%) bearing, following the current AO Guidelines (7).
After 8 weeks of restricted weight bearing, the weight bearing will be increased with 25% per week for 4 weeks.
Every time the patient and the treating physical therapist or physician have contact, the weight bearing advice given to the patient at that point in time is recorded (unloaded; partial weight bearing + clarification; full weight bearing).
Also, any additional advice given to the patient is recorded.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in functional outcome as defined by the AOFAS questionnaire
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery.
|
The American Orthopaedic Foot & Ankle Society (AOFAS) score is a clinician-based score.
It incorporates both subjective and objective information.
Patients report their pain, and physicians assess alignment.
It is designed for physicians to help standardize the assessment of patients and makes the results of this study comparable with previous data.
Scores range from 0 to 100, with healthy foot and ankles receiving 100 points.
|
0, 2, 6, 12 weeks and 6 months post-surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported function with the Maryland Foot Score
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
|
The MFS is an assessment for foot disorders, mainly consisting of the following items: pain, gait, functional activities, and cosmesis.
The scale scores have a minimum of 0 points and a maximum of 100 points.
A total score of <50 is considered as poor, 50-74 as fair, 75-89 as good, and 90-100 as excellent.
|
0, 2, 6, 12 weeks and 6 months post-surgery
|
|
Activities of Daily Living (ADL) with LEFS
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
|
The lower extremity functional scale (LEFS) is a questionnaire containing 20 questions about a person's ability to perform everyday tasks.
The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress, and outcome, as well as to set functional goals.
The LEFS can be used to evaluate the functional impairment of a patient with a disorder of one or both lower extremities.
It can be used to monitor the patient over time and to evaluate the effectiveness of an intervention.
The questionnaire consists of 80 points.
The lower the score the greater the disability.
|
0, 2, 6, 12 weeks and 6 months post-surgery
|
|
Health Related Quality of Life with EQ-5D-5L
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
|
The EuroQol 5-Dimension, 5-Level Health Scale (EQ-5D-5L) is a self-administered questionnaire, which will be completed at baseline together with the cost questionnaire at the same moments (0, 2, 6, 12 weeks and 6 months).
Both generic quality of life, as well as utilities, will be derived by means of the EQ-5D-5L, which will be administered both by the patients.
The Dutch version of the EQ-5D-5L is chosen because it is a widely used quality of life instrument (nationally and internationally) and it is recommended by the Dutch guidelines.The EQ-5D-5L contains 5 dimensions of health-related quality of life, namely mobility, self-care, daily activities, pain/discomfort and depression/anxiety.
Each dimension can be rated at five levels: no problems to major problems.
The 5 dimensions can be summed into a health state.
|
0, 2, 6, 12 weeks and 6 months post-surgery
|
|
Böhlers angle and posterior facet joint
Time Frame: Early postoperative (before first mobilization) and 6 months post-surgery
|
Radiographic evaluation by a radiologist blinded for treatment allocation will be done at the same time intervals as the scheduled visits to the physician. To see if there is a difference in the alignment of Böhlers angle and posterior facet joint alignment (radiographically measured), a CT-scan will be performed early post-operatively (before first weight bearing) and after 6 months. Differences in the Böhlers angle and posterior joint alignment (Δ = CT6months - CTpost-op.) will be calculated. The normal degree for the Böhler angle varieties between 25° and 40°. An intra-articular step off or gap from less than 2mm of the posterior facet was considered as well-reduced. |
Early postoperative (before first mobilization) and 6 months post-surgery
|
|
Medical consumption with iMCQ
Time Frame: 0 weeks and 6 months post-surgery
|
The iMTA Medical Consumption Questionnaire (iMCQ) measures health care utilization and is based on 29 questions.
It is an instrument for measuring medical consumption and is related to frequently occurring contacts with health care providers.
The iMCQ is a generic questionnaire.
It is therefore not disease specific.
The questions ask about health care related appointments patients had in the past period.
In case the respondent had no appointments, the score '0' is noted.
|
0 weeks and 6 months post-surgery
|
|
Society costs with iPCQ
Time Frame: 0 weeks and 6 months post-surgery
|
The iMTA Productivity Cost Questionnaire (iPCQ) measures productivity losses. The questionnaire is based on 12 questions. Questions 1 to 3 give information about the amount of paid work (in hours) and the number of days per week on which the respondent works. The latter provides insight into the average number of hours of work per working day of the respondent. This information is needed to calculate productivity loss costs. The questions about productivity losses form the following modules:
To calculate the costs of productivity losses, volumes are multiplied by unit cost prices. |
0 weeks and 6 months post-surgery
|
|
Occurrence of complications
Time Frame: 6 and 12 weeks and 6 months post-surgery
|
Most important complications, such as: wound infection, dislocation, non-union, - failure of osteosynthesis, postoperative arthritis
|
6 and 12 weeks and 6 months post-surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIONEER
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma Injury
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Chi-Ming HuangUMKC School of MedicineNot yet recruitingConcussion | Head Injury Trauma
-
Duke UniversityMbarara Regional Referral Hospital; Mayanja Memorial HospitalCompletedHead Injuries, Closed | Head Injury | Head Trauma | Crushing Skull Injury | Head Injuries, Multiple | Head Trauma,Closed | Head Trauma Injury | Head Trauma, Penetrating | Head Injury, Minor | Head Injury Major | Head Injury, Open | Multiple Head Injury | Trauma, Head | Craniocerebral Injury | Injury, Craniocerebral | Injury...Uganda
-
Wake Forest University Health SciencesRosalind Franklin University of Medicine and ScienceCompletedTrauma | Blunt Trauma | Blunt Injury | Accident | Multiorgan InjuryUnited States
-
Assiut UniversityNot yet recruitingChest Injury Trauma
-
New York Institute of TechnologyRecruitingHead Injury TraumaUnited States
-
Wake Forest University Health SciencesMind and Life Institute, Hadley, MassachusettsCompleted
-
Australian and New Zealand Intensive Care Research...Monash University; University College Dublin; Health Research Board, Ireland; Health... and other collaboratorsRecruitingWounds and Injuries | Trauma | Traumatic Brain Injury | Multiple Trauma | Major Trauma | Traumatic Injury | Penetrating Injury | Blunt InjuryBelgium, Australia, Ireland, Finland, New Zealand, Slovenia, Germany, Saudi Arabia, Switzerland
-
Assiut UniversityUnknown
Clinical Trials on Permissive Weight Bearing group
-
Kahramanmaras Sutcu Imam UniversityCompletedFemur Intertrochanteric FracturesTurkey
-
Allegheny Singer Research Institute (also known...TerminatedFoot and Ankle SurgeryUnited States
-
Cairo UniversityCompletedPatellofemoral Pain SyndromeEgypt
-
University of Mississippi Medical CenterNot yet recruitingAcetabulum Fractures | Pelvis FracturesUnited States, Canada
-
Maimonides Medical CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.RecruitingAnkle Fractures | Syndesmotic Injuries | Bimalleolar Fractures | Trimalleolar Fractures | Ankle Dislocation | Bimalleolar Equivalent Fracture | Maisonneuve FractureUnited States
-
Cantonal Hospital of St. GallenNot yet recruitingPost Operative Treatment After Unstable Malleolar FracturesSwitzerland
-
Hospices Civils de LyonCompletedOsteoarthritis, KneeFrance
-
Panam ClinicRecruitingFemoro Acetabular ImpingementCanada
-
Riphah International UniversityCompletedTotal Hip ReplacementPakistan
-
St. Louis UniversityCompletedDistal Femur FracturesUnited States